- Home
- AVTX vs VGI Comparison
AVTX vs VGI Comparison
Compare AVTX & VGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- VGI
- Stock Information
- Founded
- AVTX 2011
- VGI 2012
- Country
- AVTX United States
- VGI United States
- Employees
- AVTX N/A
- VGI N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- VGI Investment Managers
- Sector
- AVTX Health Care
- VGI Finance
- Exchange
- AVTX Nasdaq
- VGI Nasdaq
- Market Cap
- AVTX 90.9M
- VGI 91.4M
- IPO Year
- AVTX 2015
- VGI N/A
- Fundamental
- Price
- AVTX $9.09
- VGI $7.73
- Analyst Decision
- AVTX Strong Buy
- VGI
- Analyst Count
- AVTX 4
- VGI 0
- Target Price
- AVTX $33.00
- VGI N/A
- AVG Volume (30 Days)
- AVTX 141.8K
- VGI 46.0K
- Earning Date
- AVTX 11-07-2024
- VGI 01-01-0001
- Dividend Yield
- AVTX N/A
- VGI 12.66%
- EPS Growth
- AVTX N/A
- VGI N/A
- EPS
- AVTX N/A
- VGI N/A
- Revenue
- AVTX $820,000.00
- VGI N/A
- Revenue This Year
- AVTX N/A
- VGI N/A
- Revenue Next Year
- AVTX N/A
- VGI N/A
- P/E Ratio
- AVTX N/A
- VGI N/A
- Revenue Growth
- AVTX N/A
- VGI N/A
- 52 Week Low
- AVTX $3.95
- VGI $6.68
- 52 Week High
- AVTX $34.46
- VGI $7.99
- Technical
- Relative Strength Index (RSI)
- AVTX 37.40
- VGI 35.51
- Support Level
- AVTX $9.00
- VGI $7.57
- Resistance Level
- AVTX $9.99
- VGI $8.18
- Average True Range (ATR)
- AVTX 0.89
- VGI 0.10
- MACD
- AVTX -0.01
- VGI -0.04
- Stochastic Oscillator
- AVTX 27.07
- VGI 26.23
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About VGI Virtus Global Multi-Sector Income Fund of Beneficial Interest
Virtus Global Multi-Sector Inc is a United States-based diversified, closed-end management investment company. Its investment objective is to maximize current income while preserving capital. The Fund seeks to achieve its investment objectives by capitalizing on opportunities across undervalued areas of the global bond markets.